Home/ Compare/ GLP-1 (Semaglutide) vs AOD-9604

GLP-1 (Semaglutide) vs. AOD-9604: Community Comparison

Targeted fat loss vs systemic appetite suppression — key weight loss comparison.

GLP-1 (Semaglutide)

4.7(4,521 reports)
Reported Onset
1–4 weeks (appetite suppression), 4–12 weeks (weight loss)
Primary Use

Significant weight loss via appetite suppression and metabolic improvement.

Dose
0.25mg - 2.4mg
Frequency
Weekly
GLP-1 (Semaglutide) Experiences

AOD-9604

4.2
Reported Onset
2–4 weeks
Primary Use

Targeted fat metabolism and body composition improvement without GH-related side effects.

Dose
300mcg - 500mcg
Frequency
Daily (fasted)
AOD-9604 Experiences

Community Verdict

Targeted fat loss vs systemic appetite suppression — key weight loss comparison. The community generally selects between GLP-1 (Semaglutide) and AOD-9604 based on their specific goals and experience. Both compounds are available through physician-supervised protocols at Alukard, where a physician can help determine which is most appropriate for your situation.

Ready to Start Your Protocol?

Get a Physician-Supervised Protocol for GLP-1 (Semaglutide) or AOD-9604 at Alukard

Community experiences are a starting point — but a physician-supervised protocol from Alukard gives you pharmaceutical-grade compounds, proper dosing, lab monitoring, and the safety of medical oversight.

MD
Supervised
GMP
Certified
Labs
Monitoring
COA
Verified
Start at Alukard